OpenFilings

GT Biopharma, Inc.

Form8-K

Report Period2026-04-03

Date Filed2026-04-07

Time Filed07:05:14

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

8-K
EX-10.1
Filing on SEC Edgar